6-(2-O-Methyl-beta-D-ribofuranosyl)-3-(2-oxo-propyl)-6H-iMidazo[1,2-c]pyriMidin-5-one
Modify Date: 2024-01-14 10:42:35
![6-(2-O-Methyl-beta-D-ribofuranosyl)-3-(2-oxo-propyl)-6H-iMidazo[1,2-c]pyriMidin-5-one Structure](https://www.chemsrc.com/caspic/323/2095417-54-0.png)
6-(2-O-Methyl-beta-D-ribofuranosyl)-3-(2-oxo-propyl)-6H-iMidazo[1,2-c]pyriMidin-5-one structure
|
Common Name | 6-(2-O-Methyl-beta-D-ribofuranosyl)-3-(2-oxo-propyl)-6H-iMidazo[1,2-c]pyriMidin-5-one | ||
|---|---|---|---|---|
| CAS Number | 2095417-54-0 | Molecular Weight | 337.33 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C15H19N3O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 6-(2-O-Methyl-beta-D-ribofuranosyl)-3-(2-oxo-propyl)-6H-iMidazo[1,2-c]pyriMidin-5-one6-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-3-(2-oxopropyl)imidazo[1,2-c]pyrimidin-5(6H)-one is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 6-(2-O-Methyl-beta-D-ribofuranosyl)-3-(2-oxo-propyl)-6H-iMidazo[1,2-c]pyriMidin-5-one |
|---|
| Description | 6-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-3-(2-oxopropyl)imidazo[1,2-c]pyrimidin-5(6H)-one is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C15H19N3O6 |
|---|---|
| Molecular Weight | 337.33 |